Thrombophilia causes: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Thrombophilia}}
{{Thrombophilia}}
{{CMG}} {{AE}} {{asiri}}
{{CMG}} {{AE}} {{asiri}}


==Overview==
==Overview==
Thrombophilia may be caused by either [[Thrombophilia_classification|acquired, inherited, or, more commonly, a combination of both conditions]]. The most frequent forms of inherited thrombophilia are Factor V Leiden (20-50% prevalence in patients with recurrent venous thrombosis) and prothrombon G20210A (5-20% prevalence in patients with recurrent venous thrombosis).<ref name="pmid11309638">{{cite journal| author=Seligsohn U, Lubetsky A| title=Genetic susceptibility to venous thrombosis. | journal=N Engl J Med | year= 2001 | volume= 344 | issue= 16 | pages= 1222-31 | pmid=11309638 | doi=10.1056/NEJM200104193441607 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11309638  }} </ref><ref name="pmid24421360">{{cite journal| author=Cohoon KP, Heit JA| title=Inherited and secondary thrombophilia. | journal=Circulation | year= 2014 | volume= 129 | issue= 2 | pages= 254-7 | pmid=24421360 | doi=10.1161/CIRCULATIONAHA.113.001943 | pmc=3979345 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24421360  }} </ref>
Thrombophilia may be caused by either acquired, inherited, or, more commonly, a combination of both conditions.  


==Causes==
==Causes==
===Inherited===
===Inherited===
Common types:
Common inherited causes of thrombophilia include:
* [[Factor V Leiden]]: Factor V is a procoagulant which upon activation promotes the formation of thrombin. In 1994, Bertina and colleagues identified a single nucleotide polymorphism (guanine to adenine substitution in nucleotide 1691), which rendered factor V resistant to proteolytic inactivation by activated protein C (APC).<ref name="pmid8164741">{{cite journal| author=Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H et al.| title=Mutation in blood coagulation factor V associated with resistance to activated protein C. | journal=Nature | year= 1994 | volume= 369 | issue= 6475 | pages= 64-7 | pmid=8164741 | doi=10.1038/369064a0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8164741  }} </ref>  
* [[Factor V Leiden]]: Factor V is a procoagulant which upon activation promotes the formation of thrombin. In 1994, Bertina and colleagues identified a single nucleotide polymorphism (guanine to adenine substitution in nucleotide 1691), which rendered factor V resistant to proteolytic inactivation by activated protein C (APC).<ref name="pmid8164741">{{cite journal| author=Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H et al.| title=Mutation in blood coagulation factor V associated with resistance to activated protein C. | journal=Nature | year= 1994 | volume= 369 | issue= 6475 | pages= 64-7 | pmid=8164741 | doi=10.1038/369064a0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8164741  }} </ref>  
* [http://emedicine.medscape.com/article/209742-overview Prothrombin G20210A]: [[Prothrombin]], or factor II, is a precursor to throbmin. A single nucleotide polymorphism (guanine to adenonine substitution in in nucleotide 20210) was first identied by Poort and colleages in 1996. The mutation was associated with elevated prothrombin, thought to be due to increased translation efficiency, and an increased risk of thrombosis.<ref name="pmid8916933">{{cite journal| author=Poort SR, Rosendaal FR, Reitsma PH, Bertina RM| title=A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. | journal=Blood | year= 1996 | volume= 88 | issue= 10 | pages= 3698-703 | pmid=8916933 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8916933  }} </ref>   
* [http://emedicine.medscape.com/article/209742-overview Prothrombin G20210A]: [[Prothrombin]], or factor II, is a precursor to throbmin. A single nucleotide polymorphism (guanine to adenonine substitution in in nucleotide 20210) was first identied by Poort and colleages in 1996. The mutation was associated with elevated prothrombin, thought to be due to increased translation efficiency, and an increased risk of thrombosis.<ref name="pmid8916933">{{cite journal| author=Poort SR, Rosendaal FR, Reitsma PH, Bertina RM| title=A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. | journal=Blood | year= 1996 | volume= 88 | issue= 10 | pages= 3698-703 | pmid=8916933 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8916933  }} </ref>   
* Coinheritance of multiple thrombophilias is not infrequent, and does increase the thrombotic risk in affected patients.  
* Coinheritance of multiple thrombophilias is not infrequent, and does increase the thrombotic risk in affected patients.  


Rare forms:
Rare causes of thrombophilia include:
* [[Antithrombin|Antithrombin III]] deficiency
* [[Antithrombin|Antithrombin III]] deficiency
* [[Protein C deficiency]]
* [[Protein C deficiency]]
Line 24: Line 23:
**Additional mutations in the cleavage site of factor V by APC  
**Additional mutations in the cleavage site of factor V by APC  
* Increased levels of [[Factor_VIII|factor VIII]], [[Factor_IX|factor IX]], [[Factor_XI|factor XI]], or [[fibrinogen]]
* Increased levels of [[Factor_VIII|factor VIII]], [[Factor_IX|factor IX]], [[Factor_XI|factor XI]], or [[fibrinogen]]
===Acquired and Mixed/Unknown===
* Refer to [[Thrombophilia_classification|thrombophilia classification]]


==Causes of Thrombophilia by Organ System==
==Causes of Thrombophilia by Organ System==
Line 97: Line 93:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Disease]]
[[Category:Disease]]
[[Category:Hematology]]
[[Category:Hematology]]

Revision as of 15:59, 19 July 2016

Thrombophilia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thrombophilia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thrombophilia causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thrombophilia causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombophilia causes

CDC on Thrombophilia causes

Thrombophilia causes in the news

Blogs on Thrombophilia causes

Directions to Hospitals Treating Thrombophilia

Risk calculators and risk factors for Thrombophilia causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Asiri Ediriwickrema, M.D., M.H.S. [2]

Overview

Thrombophilia may be caused by either acquired, inherited, or, more commonly, a combination of both conditions.

Causes

Inherited

Common inherited causes of thrombophilia include:

  • Factor V Leiden: Factor V is a procoagulant which upon activation promotes the formation of thrombin. In 1994, Bertina and colleagues identified a single nucleotide polymorphism (guanine to adenine substitution in nucleotide 1691), which rendered factor V resistant to proteolytic inactivation by activated protein C (APC).[1]
  • Prothrombin G20210A: Prothrombin, or factor II, is a precursor to throbmin. A single nucleotide polymorphism (guanine to adenonine substitution in in nucleotide 20210) was first identied by Poort and colleages in 1996. The mutation was associated with elevated prothrombin, thought to be due to increased translation efficiency, and an increased risk of thrombosis.[2]
  • Coinheritance of multiple thrombophilias is not infrequent, and does increase the thrombotic risk in affected patients.

Rare causes of thrombophilia include:

Causes of Thrombophilia by Organ System

Cardiovascular Cerebral vein thrombosisAcute myocardial infarctionDeep vein thrombophlebitisPortal vein thrombosisPelvic thrombophlebitis
Drug Side Effect Asparaginasebevacizumabcombined oral contraceptive pillcertolizumab pegolCcproteronediethylstilboestroldrospirenoneeltrombopagerythropoietinethinylestradiolfosfestrolgranulocyte-macrophage colony stimulating factorheparinhormone replacement therapylenalidomidepeginesatidepolyestradiolraloxifenestrontium ranelatetamoxifentobacco smokingtranexamic acidvorinostat
Endocrine Hyperosmolar non-ketotic diabetic coma
Gastroenterologic • Acute pancreatitisPortal hypertension
Genetic Congenital DysfibrinogenemiaFactor II mutationHereditary thrombophlebitisAntithrombin III deficiencyFactor V Leiden mutationProtein C deficiencyProtein S deficiencyKlippel-Trenaunay syndromeKlinefelter syndromeSickle cell diseaseCarbohydrate-deficient glycoprotein syndrome type 1bFactor XII deficiencyHaemoglobin SC diseaseHyperprothrombinemia 20210G-APlasminogen deficiencyActivated protein C resistanceCD59 antigen deficiencyCystathionine beta-synthase deficiency
Hematologic Polycythemia veraEssential thrombocythemiaMyeloproliferative diseaseHyperviscosity syndrome • Paroxysmal Nocturnal HemoglobinuriaThrombocytosis • Raised homocysteine levels
Iatrogenic • Surgical complication
Infectious Disease Intraperitoneal abscessAcute peritonitisVisceral abscessDiverticulitisIntravenous catheter infection
Musculoskeletal / Ortho • Orthopedic surgeries • Abdominal surgery
Nutritional / Metabolic CystathionuriaHomocystinuriaMethyltetrahydrofolate reductase deficiencyMetabolic SyndromeInsulin resistanceFolic acid deficiencyObesity
Obstetric/Gynecologic PregnancyPuerperium periodOvarian hyperstimulation syndrome
Oncologic MalignancyPeritoneal metastasisAdenocarcinoma of cecumAdenocarcinoma of colon • Occult malignancy • LeukemiaPancreatic cancerGlucagonoma
Renal / Electrolyte Chronic renal failureParoxysmal Nocturnal HemoglobinuriaNephrotic syndrome
Rheum / Immune / Allergy Antiphospholipid SyndromeCirculating anticoagulantHeparin induced thrombocytopeniaInflammatory bowel diseaseCrohn's diseaseBehcet diseaseHughes-Stovin syndromePolyarteritis NodosaSLE
Trauma TraumaAbdominal trauma
Miscellaneous Paraneoplastic syndromeHypereosinophilic syndromeImmobility

References

  1. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H; et al. (1994). "Mutation in blood coagulation factor V associated with resistance to activated protein C." Nature. 369 (6475): 64–7. doi:10.1038/369064a0. PMID 8164741.
  2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996). "A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis". Blood. 88 (10): 3698–703. PMID 8916933.

Template:WH Template:WS